Formation and Composition. Following [***], as soon as reasonably possible and in any event within [***] days thereafter, the Parties shall establish a joint development committee (the “JDC”), which will serve as a forum for the exchange of information with respect to the Development of the Collaboration Off-the-Shelf T-Cell Therapies Directed To each Collaboration Target for which an Opt-In is in effect. The JDC shall be composed of representatives designated by each Party. Representatives must be appropriate for the tasks then being undertaken in terms of their seniority, availability, function in their respective organizations, training and experience. Each Party shall designate one of its representatives as its primary JDC contact. Each Party may replace its representatives from time to time by informing the other Party’s Alliance Manager in writing (which may be by email); provided, that if a Party’s representative is unable to attend a meeting, such Party may designate an alternate to attend such meeting by informing the other Party’s Alliance Manager in writing (which may be by email) in advance and following submission of such written notification the alternate will be entitled to perform the functions of such representative. The Alliance Managers may attend meetings of the JDC.
Appears in 1 contract
Samples: Strategic Collaboration and License Agreement (Adaptimmune Therapeutics PLC)
Formation and Composition. Following [***], as As soon as reasonably possible and in any event within after […***] days thereafter…], the Parties Adaptimmune and Bellicum shall establish a joint development committee (the “JDC”), which will serve as a forum for ) to monitor and coordinate the exchange communication and activities of information with respect to the both Parties under each Co-Development of the Collaboration Off-the-Shelf T-Cell Therapies Directed To each Collaboration Target for which an Opt-In is in effectPlan. The JDC shall be composed of at least […***…] but no more than […***…] representatives designated by each Party and in each case an equal number of representatives from each Party. Representatives must be appropriate for the tasks then being undertaken and the applicable stage of research, pre-clinical development or clinical development, in terms of their seniority, decision-making authority, availability, function in their respective organizationsorganisations, training and experience. Each Party shall designate one of its representatives as its primary JDC contact. Each Party may replace its JDC representatives from time to time by informing upon written notice to the Alliance Manager of the other Party’s Alliance Manager in writing (which may be by email); provided, that however, if a Party’s JDC representative is unable to attend a JDC meeting, such Party may designate an alternate to attend such JDC meeting by informing providing notification in writing to the other Party’s Alliance Manager in writing (which may be by email) in advance and following submission provision of such written notification the alternate will be entitled to perform the functions of such representativeJDC representative at such JDC meeting. The Alliance Managers may attend meetings of the JDC but shall have no right to vote on any decisions of the JDC.. 132265684 v23 Page 15
Appears in 1 contract
Samples: Co Development and Co Commercialisation Agreement (Bellicum Pharmaceuticals, Inc)
Formation and Composition. Following [***], as As soon as reasonably possible and in any event within [***] days thereafter* after the Effective Date, the Parties Adaptimmune and Bellicum shall establish a joint development steering committee (the “JDCJSC”), which will serve as a forum for ) to monitor and coordinate the exchange communication and activities of information with respect to the Development of the Collaboration Off-the-Shelf T-Cell Therapies Directed To each Collaboration Target for which an Opt-In is in effectboth Parties under this Agreement. The JDC JSC shall be composed of at least *** but no more than *** representatives designated by each Party and in each case an equal number of representatives from each Party. Representatives must be appropriate for the tasks then being undertaken and the stage of development or commercialisation applicable, in terms of their seniority, decision-making authority, availability, function in their respective organizations, training and experience. Each Party shall designate one of its representatives as its primary JDC contact. Each Party may replace its JSC representatives from time to time by informing upon written notice to the other Party’s Alliance Manager in writing (which may be by email); provided, that however, if a Party’s JSC representative is unable to attend a JSC meeting, such Party may designate an alternate to attend such JSC meeting by informing providing notification in writing to the other Party’s Alliance Manager in writing (which may be by email) in advance and following submission provision of such written notification the alternate will be entitled to perform the functions of such representativeJSC representative at such JSC meeting. The Alliance Managers may attend meetings of the JDCJSC but shall have no right to vote on any decisions of the JSC.
Appears in 1 contract
Samples: Co Development and Co Commercialisation Agreement (Adaptimmune Therapeutics PLC)
Formation and Composition. Following [***], as As soon as reasonably possible and in any event within [after ***] days thereafter* , the Parties Adaptimmune and Bellicum shall establish a joint development committee (the “JDC”), which will serve as a forum for ) to monitor and coordinate the exchange communication and activities of information with respect to the both Parties under each Co-Development of the Collaboration Off-the-Shelf T-Cell Therapies Directed To each Collaboration Target for which an Opt-In is in effectPlan. The JDC shall be composed of at least *** but no more than *** representatives designated by each Party and in each case an equal number of representatives from each Party. Representatives must be appropriate for the tasks then being undertaken and the applicable stage of research, pre-clinical development or clinical development, in terms of their seniority, decision-making authority, availability, function in their respective organizationsorganisations, training and experience. Each Party shall designate one of its representatives as its primary JDC contact. Each Party may replace its JDC representatives from time to time by informing upon written notice to the Alliance Manager of the other Party’s Alliance Manager in writing (which may be by email); provided, that however, if a Party’s JDC representative is unable to attend a JDC meeting, such Party may designate an alternate to attend such JDC meeting by informing providing notification in writing to the other Party’s Alliance Manager in writing (which may be by email) in advance and following submission provision of such written notification the alternate will be entitled to perform the functions of such representativeJDC representative at such JDC meeting. The Alliance Managers may attend meetings of the JDC but shall have no right to vote on any decisions of the JDC.
Appears in 1 contract
Samples: Co Development and Co Commercialisation Agreement (Adaptimmune Therapeutics PLC)
Formation and Composition. Following [***], as As soon as reasonably possible after Acceptance Date for any Target, Adaptimmune and in any event within [***] days thereafter, the Parties Noile-Immune shall establish a joint development committee (the “JDCJPT”), which will serve as a forum ) to monitor and coordinate the communication and activities of both Parties under the applicable Research Plan for the exchange of information with respect to the Development of the Collaboration Off-the-Shelf T-Cell Therapies Directed To each Collaboration Target for which an Opt-In is in effectNominated Target. The JDC JPT shall be composed of at least two (2) but no more than three (3) representatives designated by each Party and in each case an equal number of representatives from each Party. Representatives must be appropriate for the tasks then being undertaken and the applicable stage of research, in terms of their seniority, decision-making authority, availability, function in their respective organizationsorganisations, training and experience. Each Party shall designate one of its representatives as its primary JDC contact. Each Party may replace its JPT representatives from time to time by informing upon written notice to the Alliance Manager of the other Party’s Alliance Manager in writing (which may be by email); provided, that however, if a Party’s JPT representative is unable to attend a JPT meeting, such Party may designate an alternate to attend such JPT meeting by informing providing notification in writing to the other Party’s Alliance Manager in writing (which may be by email) in advance and following submission provision of such written notification the alternate will be entitled to perform the functions of such representativeJPT representative at such JPT meeting. The Alliance Managers may attend meetings of the JDCJPT but shall have no right to vote on any decisions of the JPT.
Appears in 1 contract
Samples: Collaboration Agreement (Adaptimmune Therapeutics PLC)
Formation and Composition. Following [***], as As soon as reasonably possible and in any event within […***…] days thereafterafter the Effective Date, the Parties Adaptimmune and Bellicum shall establish a joint development steering committee (the “JDCJSC”), which will serve as a forum for ) to monitor and coordinate the exchange communication and activities of information with respect to the Development of the Collaboration Off-the-Shelf T-Cell Therapies Directed To each Collaboration Target for which an Opt-In is in effectboth Parties under this Agreement. The JDC JSC shall be composed of at least […***…] but no more than […***…] representatives designated by each Party and in each case an equal number of representatives from each Party. Representatives must be appropriate for the tasks then being undertaken and the stage of development or commercialisation applicable, in terms of their seniority, decision-making authority, availability, function in their respective organizations, training and experience. Each Party shall designate one of its representatives as its primary JDC contact. Each Party may replace its JSC representatives from time to time by informing upon written notice to the other Party’s Alliance Manager in writing (which may be by email); provided, that however, if a Party’s JSC representative is unable to attend a JSC meeting, such Party may designate an alternate to attend such JSC meeting by informing providing notification in writing to the other Party’s Alliance Manager in writing (which may be by email) in advance and following submission provision of such written notification the alternate will be entitled to perform the functions of such representativeJSC representative at such JSC meeting. The Alliance Managers may attend meetings of the JDCJSC but shall have no right to vote on any decisions of the JSC.
Appears in 1 contract
Samples: Co Development and Co Commercialisation Agreement (Bellicum Pharmaceuticals, Inc)